RK Ventures Group
8
18M
5
0.36
0.38
3
- Stages of investment
- Areas of investment
Summary
RK Ventures Group is the famous VC, which was founded in 1999. The main department of described VC is located in the New York. The company was established in North America in United States.
The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2010. The fund is generally included in less than 2 deals every year. Opposing the other organizations, this RK Ventures Group works on 4 percentage points less the average amount of lead investments. The top activity for fund was in 2017.
We can highlight the next thriving fund investment areas, such as Therapeutics, Biotechnology. Among the various public portfolio startups of the fund, we may underline Xenex, Respicardia, Redpoint Bio For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. The fund has exact preference in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The typical case for the fund is to invest in rounds with 5-6 participants. Despite the RK Ventures Group, startups are often financed by BioAdvance, Pfizer Venture Investments, Lilly Ventures. The meaningful sponsors for the fund in investment in the same round are Pfizer Venture Investments, Lilly Ventures, BioAdvance. In the next rounds fund is usually obtained by Safeguard Scientifics, Pfizer Venture Investments, Lilly Ventures.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 0
- Exits
- 3
- Rounds per year
- 0.36
- Follow on index
- 0.38
- Investments by industry
- Health Care (4)
- Biotechnology (4)
- Medical Device (3)
- Diabetes (3)
- Pharmaceutical (3) Show 7 more
- Investments by region
-
- United States (7)
- India (1)
- Peak activity year
- 2007
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 15
- Avg. valuation at time of investment
- 160M
- Group Appearance index
- 1.00
- Avg. company exit year
- 10
- Avg. multiplicator
- 3.57
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Avid Radiopharmaceuticals | 05 Jan 2006 | Biotechnology, Pharmaceutical, Diabetes | Early Stage Venture | 8M | United States, Pennsylvania, Philadelphia |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.